Tandospirone

Drug Profile

Tandospirone

Alternative Names: Metanopirone; Sediel; SM 3997

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dainippon Sumitomo Pharma
  • Developer Dainippon Sumitomo Pharma; Pfizer; Sumitomo Dainippon Pharma
  • Class Anxiolytics; Eye disorder therapies; Isoindoles; Piperazines; Pyrimidines
  • Mechanism of Action Serotonin 1A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Anxiety disorders; Generalised anxiety disorder
  • Discontinued Eating disorders; Major depressive disorder; Nausea and vomiting

Most Recent Events

  • 19 Jun 2014 Dainippon Sumitomo Pharma is now called Sumitomo Dainippon Pharma
  • 01 Oct 2005 Sumitomo Pharmaceuticals has merged with Dainippon Pharmaceutical to form Dainippon Sumitomo Pharma
  • 02 Mar 2004 Launched for Generalised anxiety disorder in China (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top